title: Hyperlipidemia and primary prevention of stroke: does risk factor identification and reduction really work?
abstract: Stroke is one of the leading causes of death. Hyperlipidemia is a major risk factor for stroke. The United States Preventive Service Task Force defines lipid screening guidelines. Treatment options of hyperlipidemia include lifestyle modifications and medical management. Statins have been shown to decrease lipids and exert a pleiotropic effect on intracranial vasculature and inflammatory modulators, leading to neuroprotection. Lower low-density lipoprotein and higher high-density lipoprotein levels are associated with decreased risk of stroke. Despite screening guidelines and evidence of the efficacy of statins, there are numerous barriers to maintaining adequate control of lipids.
authors.affiliation: Department of Neurology, New York Presbyterian Hospital, Weill Cornell, NY 10065, USA.
authors.forename: Ariane
authors.initials: A
authors.lastname: Lewis
authors.forename: Alan
authors.initials: A
authors.lastname: Segal
mesh_terms: D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D008297:Male; D008403:Mass Screening; D012307:Risk Factors; D040242:Risk Reduction Behavior; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors